Is Ketamine Addictive in the Treatment of Treatment-Resistant Depression?

Ketamine has emerged as a promising treatment option for individuals struggling with treatment-resistant depression (TRD). It offers quick relief as well as hope for those who have not responded to traditional antidepressant medications or treatments. However, concerns about the addictive potential of ketamine have led to misconceptions about its use in depression treatment. At Delray Brain Science, we believe in providing accurate information and debunking myths surrounding ketamine therapy. So, Is ketamine addictive when used in the treatment of treatment-resistant depression?

The Use of Ketamine Therapy in the Treatment of TRD

Ketamine is an FDA-approved anesthetic medication that has been used for decades in medical settings. Recently, ketamine has garnered attention for its fast-acting antidepressant properties, specifically in individuals diagnosed with TRD. Ketamine works by engaging with the brain’s glutamate system, promoting the growth of new neural connections. And, restoring balance to neurotransmitter activity that has to do with depression.

Ketamine therapy for TRD typically involves intravenous (IV) infusions or intranasal administration of ketamine under medical supervision. These treatments are administered in a controlled clinical setting, allowing clinicians to monitor patients closely and ensure their safety throughout the procedure.

Is Ketamine Addictive?

Contrary to popular belief, ketamine has a low potential for addiction when used in medical settings for the treatment of depression. The doses used in ketamine therapy for TRD are much lower than those used recreationally or in anesthesia. Thus, minimizing the risk of dependence and eliminating the chance of misuse.

Ketamine therapy is typically administered in a series of treatments over a specified treatment plan. Overall, the goal of these treatment plans is to achieve remission of depressive symptoms. Once remission is achieved, maintenance treatments may be recommended to sustain the symptom-relieving benefits of ketamine therapy. However, patients do not develop tolerance to ketamine’s antidepressant effects. Therefore, the dose does not need to be continuously increased over time to maintain benefits.

Furthermore, the therapeutic effects of ketamine differ from the euphoric or dissociative effects that are associated with recreational ketamine use. Patients undergoing ketamine therapy for TRD report improvements in mood, motivation, and overall well-being, rather than seeking ketamine for its psychoactive effects.

At Delray Brain Science, we make patient safety and well-being the priority throughout the ketamine therapy process. Our experienced clinicians conduct thorough assessments, monitor patients closely during treatment sessions, and provide support to ensure the best outcomes of ketamine therapy for TRD.

Choosing Ketamine Therapy for TRD

Ketamine therapy offers hope to individuals struggling with treatment-resistant depression who haven’t gotten the results they want with other treatments. Contrary to myths about ketamine’s addictive properties in medical settings, ketamine has a low potential for addiction when used in the treatment of TRD. At Delray Brain Science, we’re dedicated to providing accurate information and evidence-based treatments to help individuals overcome the debilitating symptoms of depression. If you are struggling with treatment-resistant depression, contact Delray Brain Science today to learn more about ketamine therapy and explore your treatment options.